BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 9020887)

  • 1. Mechanism of inactivation of myeloperoxidase by 4-aminobenzoic acid hydrazide.
    Kettle AJ; Gedye CA; Winterbourn CC
    Biochem J; 1997 Jan; 321 ( Pt 2)(Pt 2):503-8. PubMed ID: 9020887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient and steady-state kinetics of the oxidation of substituted benzoic acid hydrazides by myeloperoxidase.
    Burner U; Obinger C; Paumann M; Furtmüller PG; Kettle AJ
    J Biol Chem; 1999 Apr; 274(14):9494-502. PubMed ID: 10092633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of myeloperoxidase by benzoic acid hydrazides.
    Kettle AJ; Gedye CA; Hampton MB; Winterbourn CC
    Biochem J; 1995 Jun; 308 ( Pt 2)(Pt 2):559-63. PubMed ID: 7772042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of oxidizing agents on human plasma alpha 1-proteinase inhibitor and human neutrophil myeloperoxidase.
    Matheson NR; Travis J
    Biochemistry; 1985 Apr; 24(8):1941-5. PubMed ID: 2990544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ordered cleavage of myeloperoxidase ester bonds releases active site heme leading to inactivation of myeloperoxidase by benzoic acid hydrazide analogs.
    Huang J; Smith F; Panizzi P
    Arch Biochem Biophys; 2014 Apr; 548():74-85. PubMed ID: 24632143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Myeloperoxidase Activity in Cystic Fibrosis Sputum by Peptide Inhibitor of Complement C1 (PIC1).
    Hair PS; Sass LA; Krishna NK; Cunnion KM
    PLoS One; 2017; 12(1):e0170203. PubMed ID: 28135312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A kinetic analysis of the catalase activity of myeloperoxidase.
    Kettle AJ; Winterbourn CC
    Biochemistry; 2001 Aug; 40(34):10204-12. PubMed ID: 11513598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superoxide is an antagonist of antiinflammatory drugs that inhibit hypochlorous acid production by myeloperoxidase.
    Kettle AJ; Gedye CA; Winterbourn CC
    Biochem Pharmacol; 1993 May; 45(10):2003-10. PubMed ID: 8390258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myricitrin as a substrate and inhibitor of myeloperoxidase: implications for the pharmacological effects of flavonoids.
    Meotti FC; Senthilmohan R; Harwood DT; Missau FC; Pizzolatti MG; Kettle AJ
    Free Radic Biol Med; 2008 Jan; 44(1):109-20. PubMed ID: 17963707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoniazid as a substrate and inhibitor of myeloperoxidase: identification of amine adducts and the influence of superoxide dismutase on their formation.
    Forbes LV; Furtmüller PG; Khalilova I; Turner R; Obinger C; Kettle AJ
    Biochem Pharmacol; 2012 Oct; 84(7):949-60. PubMed ID: 22846601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling the reactions of superoxide and myeloperoxidase in the neutrophil phagosome: implications for microbial killing.
    Winterbourn CC; Hampton MB; Livesey JH; Kettle AJ
    J Biol Chem; 2006 Dec; 281(52):39860-9. PubMed ID: 17074761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoniazid-mediated irreversible inhibition of the myeloperoxidase antimicrobial system of the human neutrophil and the effect of thyronines.
    van Zyl JM; Basson K; Uebel RA; van der Walt BJ
    Biochem Pharmacol; 1989 Jul; 38(14):2363-73. PubMed ID: 2546565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The chlorinating activity of human myeloperoxidase: high initial activity at neutral pH value and activation by electron donors.
    Zuurbier KW; Bakkenist AR; Wever R; Muijsers AO
    Biochim Biophys Acta; 1990 Feb; 1037(2):140-6. PubMed ID: 2155024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of human myeloperoxidase by hydrogen peroxide.
    Paumann-Page M; Furtmüller PG; Hofbauer S; Paton LN; Obinger C; Kettle AJ
    Arch Biochem Biophys; 2013 Nov; 539(1):51-62. PubMed ID: 24035742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superoxide modulates the activity of myeloperoxidase and optimizes the production of hypochlorous acid.
    Kettle AJ; Winterbourn CC
    Biochem J; 1988 Jun; 252(2):529-36. PubMed ID: 2843172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin as a physiological substrate for myeloperoxidase and its superoxide-dependent oxidation to cytotoxic tryptamine-4,5-dione.
    Ximenes VF; Maghzal GJ; Turner R; Kato Y; Winterbourn CC; Kettle AJ
    Biochem J; 2009 Dec; 425(1):285-93. PubMed ID: 19828014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidation of tryptophan by redox intermediates of myeloperoxidase and inhibition of hypochlorous acid production.
    Kettle AJ; Candaeis LP
    Redox Rep; 2000; 5(4):179-84. PubMed ID: 10994871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidation of hydroquinone by myeloperoxidase. Mechanism of stimulation by benzoquinone.
    Kettle AJ; Winterbourn CC
    J Biol Chem; 1992 Apr; 267(12):8319-24. PubMed ID: 1314822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative inactivation of myeloperoxidase released from human neutrophils.
    Edwards SW; Nurcombe HL; Hart CA
    Biochem J; 1987 Aug; 245(3):925-8. PubMed ID: 2822034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of chlorination of monochlorodimedone by myeloperoxidase.
    Jerlich A; Tschabuschnig S; Fabjan JS; Schaur RJ
    Int J Clin Lab Res; 2000; 30(1):33-7. PubMed ID: 10984130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.